Inhaled β-agonist does not modify sympathetic activity in patients with COPD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhaled β-agonist does not modify sympathetic activity in patients with COPD ; volume:15 ; number:1 ; day:30 ; month:4 ; year:2015 ; pages:1-10 ; date:12.2015
BMC pulmonary medicine ; 15, Heft 1 (30.4.2015), 1-10, 12.2015
- Urheber
-
Haarmann, Helge
- Beteiligte Personen und Organisationen
-
Mohrlang, Cordula
Tschiesner, Uta
Rubin, David B.
Bornemann, Thore
Rüter, Karin
Bonev, Slavtcho
Raupach, Tobias
Hasenfuß, Gerd
Andreas, Stefan
SpringerLink (Online service)
- DOI
-
10.1186/s12890-015-0054-7
- URN
-
urn:nbn:de:1111-2016110923239
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haarmann, Helge
- Mohrlang, Cordula
- Tschiesner, Uta
- Rubin, David B.
- Bornemann, Thore
- Rüter, Karin
- Bonev, Slavtcho
- Raupach, Tobias
- Hasenfuß, Gerd
- Andreas, Stefan
- SpringerLink (Online service)
Ähnliche Objekte (12)
COPD: Kurz wirksame Beta-Agonisten oft übermäßig gebraucht
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn
Sympathetic and Vagal Nerve Activity in COPD : Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential
Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
COPD: Kurz wirksame Beta-Agonisten oft übermäßig gebraucht
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn
Sympathetic and Vagal Nerve Activity in COPD : Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential
Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
COPD: Kurz wirksame Beta-Agonisten oft übermäßig gebraucht
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn
Sympathetic and Vagal Nerve Activity in COPD : Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential
Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review